Scientific Session
Vasculitis
Brad Rovin, MD
The Ohio State University
Columbus, OH, United States
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); Aurinia: Consultant (Ongoing), Grant/Research Support (Ongoing); Biogen: Consultant (Ongoing); F. Hoffmann-La Roche Ltd: Consultant (Ongoing); Genentech: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Novartis: Consultant (Ongoing)